Notably, using a co-transfer model of NRP1-intact and NRP1-deficient Tregs, interferon (IFN)-γ produced by NRP1-deficient Tregs is capable of causing fragility to the suppressive capacity of NRP1-intact Tregs, resulting in improved host anti-tumor immunity (70). The gene discussed is NRP1; the disease is neoplasm.